Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -.--% | -.--% |
22/05 | Deutsche Bank Adjusts Waters Price Target to $330 From $304 | MT |
16/05 | Waters Corp Insider Sold Shares Worth $1,446,560, According to a Recent SEC Filing | MT |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- With an expected P/E ratio at 31.15 and 27.38 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 2TCr | - | ||
+10.03% | 22TCr | B | ||
+13.59% | 19TCr | B- | ||
+20.01% | 14TCr | B- | ||
+30.83% | 11TCr | A- | ||
+2.05% | 6.5TCr | A- | ||
+15.38% | 5.3TCr | B+ | ||
+3.96% | 5.04TCr | B+ | ||
+8.37% | 4.42TCr | A | ||
+3.27% | 3.64TCr | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- WAT Stock
- WAZ Stock
- Ratings Waters Corporation